HIV Prevention Intervention for Young Transgender Women (LifeSkills)

This study is currently recruiting participants.
Verified April 2012 by Ann & Robert H Lurie Children's Hospital of Chicago
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Ann & Robert H Lurie Children's Hospital of Chicago
ClinicalTrials.gov Identifier:
NCT01575938
First received: March 29, 2012
Last updated: April 12, 2012
Last verified: April 2012
  Purpose

The purpose of this study is to test the efficacy of a uniquely targeted HIV risk reduction intervention for young transgender women (YTW), ages 16 to 24, at risk for HIV acquisition or transmission.


Condition Intervention
Sexual Transmission of Infection
Behavioral: HIV prevention intervention
Behavioral: Diet and Nutrition
Other: Standard of care

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: HIV Prevention Intervention for Young Transgender Women

Resource links provided by NLM:


Further study details as provided by Ann & Robert H Lurie Children's Hospital of Chicago:

Primary Outcome Measures:
  • Change from baseline in number of unprotected anal sex acts in the previous 4 months [ Time Frame: Baseline, 4-months post-intervention ] [ Designated as safety issue: No ]
    Self-reported unprotected anal sex acts in the previous 4 months assessed via computer-assisted self-interviewing.


Estimated Enrollment: 375
Study Start Date: March 2012
Estimated Study Completion Date: March 2016
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: HIV group-based prevention intervention
The intervention is a 6-session group-based and manualized intervention. Participants will also receive HIV and STI testing and counseling prior to the start of the intervention.
Behavioral: HIV prevention intervention
The 6-session HIV prevention intervention curriculum, "LifeSkills," incorporates interactive activities, in-depth discussions, videos, games, and role-plays to help young transgender women develop, practice, and integrate new skills into "real-life" situations. Activities address each aspect our theoretical framework (information, motivation, behavior), including experiences that may pre-dispose young transgender women to HIV/STI risk.
Active Comparator: Diet and nutrition
The comparison condition is a 6-session group-based and manualized health promotion intervention. Participants will also receive HIV and STI testing and counseling prior to the start of the intervention.
Behavioral: Diet and Nutrition
The comparison condition is a 6-session group-based and manualized health promotion intervention. Participants will also receive HIV and STI testing and counseling prior to the start of the intervention.
No Intervention: Standard-of-care
This arm will receive HIV and STI testing and counseling only.
Other: Standard of care
This arm will receive HIV and STI testing and counseling only.

Detailed Description:

The purpose of this study is to test the efficacy of a uniquely targeted HIV risk reduction intervention for young transgender women (YTW), ages 16 to 24, at risk for HIV acquisition or transmission. The study will test this intervention in a three-arm randomized controlled trial in two major U.S. cities with excellent access to and research experience with the population (Chicago, Boston). We will enroll 375 at risk YTW, ages 16-24; two-fifths of the sample (N=150) randomized to the intervention will participate in the 6-session group-based and manualized Life Skills intervention; two-fifths (N=150) will be randomized to the standard-of-care (SOC) control condition; and one-fifth will be randomized to the time-matched attention control condition (N=75) and receive standard health promotion information in a group-based multi-session format. All three arms will receive HIV and STI (Chlamydia and gonorrhea) testing and pre-posttest risk reduction counseling (i.e., SOC). Sexual risk will be assessed at baseline, 4, 8 and 12 months post-intervention Our specific aims are: 1) to determine the efficacy of the Life Skills intervention in comparison to a SOC arm and a time-matched attention control on the primary outcome: number of unprotected anal sex acts (UAS) (in the previous four months) among YTW, ages 16-24; and 2) to examine the degree to which improvements in sexual risk taking are mediated by the conceptual mediators of the intervention: transgender adaptation and integration, collective self-esteem/empowerment, information (HIV knowledge), motivation (attitudes, norms, and intentions for safer sex), and behavioral skills (discussing sex and condom use with sexual partners, acquiring and using condoms); and to explore whether reductions in sexual risk are associated with epidemiologically-linked moderators of sexual risk behavior: age, race/ethnicity, and psychosocial factors. An additional exploratory aim is to describe the prevalence of HIV and STIs in the community recruited sample; in the SOC arm, we will assess the natural trajectory of sexual risk behavior and the acquisition of HIV and STIs (incidence rate) in YTW over a 12-month follow-up period.

  Eligibility

Ages Eligible for Study:   16 Years to 24 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • age 16-24
  • self-identified as transgender, transsexual, and/or female with a male biological or birth sex
  • self-reported history of unprotected anal or vaginal intercourse with a male partner in previous 4 months
  • able to speak and understand English
  • willing and able to provide informed consent/assent
  • intention to reside in the local area throughout the 12 month follow-up period

Exclusion Criteria:

  • unable to provide informed consent due to severe mental or physical illness, or substance intoxication at the time of interview
  • active suicidal ideation at the time of baseline interview
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01575938

Contacts
Contact: Robert Garofalo, MD 773-880-4551 rgarofalo@childrensmemorial.org

Locations
United States, Illinois
Children's Memorial Hospital Recruiting
Chicago, Illinois, United States, 60614
Principal Investigator: Robert Garofalo, MD            
United States, Massachusetts
The Fenway Institute Recruiting
Boston, Massachusetts, United States, 02215
Contact: Matthew Mimiaga, Sc.D.            
Principal Investigator: Matthew Mimiaga, Sc.D.            
Sponsors and Collaborators
Ann & Robert H Lurie Children's Hospital of Chicago
Investigators
Principal Investigator: Robert Garofalo, MD Ann & Robert H Lurie Children's Hospital of Chicago
  More Information

Additional Information:
Publications:
Responsible Party: Ann & Robert H Lurie Children's Hospital of Chicago
ClinicalTrials.gov Identifier: NCT01575938     History of Changes
Other Study ID Numbers: R01MH094323, R01MH094323
Study First Received: March 29, 2012
Last Updated: April 12, 2012
Health Authority: United States: Institutional Review Board
United States: Federal Government

Keywords provided by Ann & Robert H Lurie Children's Hospital of Chicago:
HIV infection

ClinicalTrials.gov processed this record on June 18, 2013